Supreme Court Seeks Snapdeal's Reply In Prescription Drug Sale Case
India, July 18 -- The Supreme Court has sought responses from Snapdeal and its directors on Karnataka government's plea challenging a Karnataka High Court order that quashed criminal proceedings over the alleged sale of a prescription drug through the ecommerce platform without a valid licence or doctor's prescription.
A special bench of Justices Ahsanuddin Amanullah and R Mahadevan issued notice on the state's special leave petition (SLP) and its application seeking condonation of delay on July 15, according to a Bar & Bench report.
The case relates to the sale of Suhagra-100, a Schedule H prescription medicine used to treat erectile dysfunction, through Snapdeal's online marketplace.
According to the prosecution, the medicine was sol...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.